Zhou, Sufeng
Zhu, Jinying
Sun, Xiaodi
Xie, Lijun
Zhao, Yuqing
Ding, Sijia
Wang, Lu
Chen, Juan
Zhu, Bei
Zheng, Aiping
Li, Yajuan
Zhou, Chen
Shao, Feng http://orcid.org/0000-0001-8861-7299
Funding for this research was provided by:
This study was funded by Xinjiang Tefeng Pharmaceutical Company, Ltd.
Article History
Accepted: 14 May 2023
First Online: 4 June 2023
Declarations
:
: Sufeng Zhou, Jinying Zhu, Xiaodi Sun, Lijun Xie, Yuqing Zhao, Sijia Ding, Lu Wang, Juan Chen, Bei Zhu, Chen Zhou, and Feng Shao are employees of the First Affiliated Hospital with Nanjing Medical University. Aiping Zheng is an employee of the Institute of Pharmacology and Toxicology of Academy of Military Medical Sciences. Yajuan Li is an employee of Xinjiang Tefeng Pharmaceutical Company, Ltd. The authors report no other conflicts of interest.
: This study was funded by Xinjiang Tefeng Pharmaceutical Company, Ltd.
: The data are not available in a repository, but reasonable requests can be directed to Feng Shao at jsphshaofeng@hotmail.com.
: This study was conducted according to Good Clinical Practice (GCP) following the tenets of the Declaration of Helsinki. The study was registered at chinadrugtrials.org.cn (CTR20192350). The protocol and informed consent form were approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University (Nanjing, China).
: All subjects provided written informed consent before any study-related procedures were conducted.
: Not applicable.
: Not applicable
: Conceptualization: FS, CZ, SZ. Methodology, material preparation and data collection: SZ, XS, LX, SD, LW, JC, BZ, AZ. Data analysis: JZ. Writing-original draft preparation: JZ. Writing-review and editing: SZ, JZ. Resources: YL. Supervision: FS. All authors approved the final version of the manuscript.